(VTAK) Catheter Precision, Inc. Marketing Mix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(VTAK) Catheter Precision, Inc. Complete Analysis Pack
See the Bigger Picture
This Catheter Precision, Inc. 4P's Marketing Mix Analysis explains the company’s catheter products, clinical uses, and how they’re positioned, priced, distributed, and promoted; the page already contains a real preview/sample of the analysis so you can review format and content. Purchase the full version to get the complete, ready-to-use 4P’s report.
Product
3 product lines
Catheter Precision's electrophysiology portfolio has 3 product lines: VIVO for mapping, LockeT for retention, and the Amigo Remote Catheter System for catheter control. Together, they target the core workflow in complex ablation cases, where precise mapping and stable access matter most. This focused set of 3 tools gives the Company a clear, narrow mix in a specialized medtech niche.
VIVO 3D mapping
VIVO is Catheter Precision, Inc.’s non-invasive 3D cardiac mapping system, built to locate the origin of idiopathic ventricular arrhythmias before EP procedures. It is aimed at patients with otherwise healthy hearts, helping doctors plan ablation with less guesswork. In 2025, this fits a growing EP market where speed and precision matter most.
LockeT retention device
LockeT is a suture retention device used to help secure catheters or other devices in clinical settings. It sits in Catheter Precision, Inc.’s accessory-style product set, so it supports the core workflow without being the main capital item. The Company has not disclosed standalone 2025/2026 revenue for LockeT in public filings, so its value is tracked through broader product-use demand.
Amigo robotic control
Amigo robotic control is Catheter Precision, Inc.'s remote catheter system with robotic arm control, built for precise catheter movement in electrophysiology. That matters in a field where catheter tip placement can shift by millimeters, so tighter control can support procedural accuracy and consistency.
- Remote robotic arm control
- Precise catheter movement
- Supports EP accuracy
Arrhythmia care focus
Catheter Precision, Inc. centers its product story on cardiac arrhythmias, serving U.S. patients, hospitals, and electrophysiologists with tools built for EP workflows. This focus matches a large U.S. need: atrial fibrillation affects an estimated 6.1 million people, and arrhythmia care remains a high-volume hospital service line.
- Core use: electrophysiology workflow
- Target users: patients, hospitals, physicians
- Market: U.S. arrhythmia care
Catheter Precision’s Tight EP Toolkit Targets a Big AF Market
Catheter Precision, Inc. keeps its Product mix tight: VIVO for non-invasive EP mapping, LockeT for catheter retention, and Amigo for remote catheter control. The set supports one workflow, so product demand depends on procedure volume more than broad consumer sales. AF affects an estimated 6.1 million people in the U.S., which keeps EP need high.
| Product | Role |
|---|---|
| VIVO | 3D cardiac mapping |
| LockeT | Suture retention |
| Amigo | Remote catheter control |
What is included in the product
Detailed Word Document
Provides a concise, company-specific 4P analysis of Catheter Precision, Inc.’s product, pricing, placement, and promotion strategy.
Editable Excel File
Turns Catheter Precision’s 4P strategy into a quick, clear snapshot that helps teams spot and solve marketing gaps fast.
Reference Sources
Provides a concise, traceable bibliography of industry reports, government data, and benchmarks to speed due diligence and validate key market and unit-economics assumptions.
Place
Fort Mill, SC
Catheter Precision, Inc. is headquartered in Fort Mill, South Carolina, and uses the town as its corporate base for U.S. medical device operations. Fort Mill gives the company a South Carolina hub near the Charlotte metro, helping support sales, administration, and product rollout. For 2025, the company reported about $2.0 million in revenue, with Fort Mill anchoring its U.S. operating footprint.
U.S. market focus
Catheter Precision, Inc. says its mission is to improve outcomes for U.S. patients, and its commercial plan is built around the United States. That makes the U.S. its primary market place. In FY2025, this matters because U.S. hospitals and electrophysiology labs remain the core channel for its products, so growth depends on domestic adoption first.
Hospital channel
Catheter Precision, Inc. sells its electrophysiology devices into hospitals, where procurement is handled by clinical and purchasing committees, not retail buyers. This channel fits the EP market, since hospital systems make the buying call and often evaluate devices on workflow, safety, and reimbursement impact. In 2025, hospital-led buying still dominated this niche, so access to EP labs and group purchasing teams is key.
Physician users
Physician users, especially electrophysiologists, are the key place decision for Catheter Precision, Inc. because these tools only scale when they fit cath-lab workflow and individual operator preference. In the latest reported period, clinical use still depends more on physician pull than broad hospital demand, so adoption quality matters as much as procedure volume.
- Electrophysiologists drive first use and repeat use.
- Workflow fit can speed or slow adoption.
- Physician preference shapes the place channel.
EP lab setting
Catheter Precision, Inc.'s EP lab setting must fit electrophysiology labs and procedural suites where timing is tight and stock must be ready at the point of care. Distribution has to sync with case schedules, sterile use, and low-waste inventory control. In this place, shelf access and room-level availability can matter as much as the device itself.
- Fits EP labs and procedure rooms
- Matches case timing and inventory
- Supports point-of-care availability
Catheter Precision’s U.S. Hospital Channel Drives FY2025 Growth
Place for Catheter Precision, Inc. is Fort Mill, South Carolina, with the United States as the main market and hospitals as the main buying site. In FY2025, revenue was about $2.0 million, so access to U.S. electrophysiology labs and hospital committees is the key channel for adoption. Physician use in the EP lab drives placement and repeat orders.
| Place factor | FY2025 detail |
|---|---|
| Headquarters | Fort Mill, South Carolina |
| Main market | United States |
| Core channel | Hospitals and EP labs |
| Revenue | About $2.0 million |
What You See Is What You Get
Catheter Precision, Inc. Reference Sources
The preview shown here is the actual document you’ll receive instantly after purchase—no surprises. It’s the full Catheter Precision, Inc. 4P’s Marketing Mix analysis, editable and ready to use, with product, price, place, and promotion insights tailored for immediate implementation.
Promotion
Physician education
Catheter Precision, Inc. uses physician education to reach electrophysiologists and hospital teams, because direct clinical training is a key driver of medical device adoption. The pitch centers on product use and clinical value, which matters in a field where more than 1 million ablation procedures are performed globally each year. Education shortens the path from trial to routine use.
Clinical outcomes
Catheter Precision, Inc. promotes VIVO as a non-invasive mapping tool that helps physicians locate arrhythmia sources before ablation. The core message is clinical performance: better treatment precision, faster planning, and improved outcomes for arrhythmia patients. That patient-result focus is the main promotional theme, not device specs alone.
Hospital outreach
Hospital outreach is the right promotion channel for Catheter Precision, Inc. because the buyer is a committee, not a consumer: clinical fit, workflow impact, and reimbursement drive the sale. With 6,000+ U.S. hospitals to reach, targeted calls, peer education, and surgeon demos matter more than mass ads. One closed hospital account can outweigh many small leads, so outreach must prove outcomes and purchasing value fast.
Product differentiation
Catheter Precision, Inc. markets a two-product portfolio built on precision and non-invasive use: Amigo for robotic catheter control and LockeT for retention support. That makes product differentiation the main promotion message, because both tools aim to improve control and stability without adding invasive steps.
- 2 core differentiated products
- Amigo: robotic catheter control
- LockeT: retention support
- Precision and non-invasive focus
Corporate communications
Catheter Precision, Inc. uses public-company communications to build awareness, and in 2025 its investor updates and press releases kept product progress in view for clinicians and market watchers. With 2 marketed systems, VIVO and LockeT, the company can link clinical milestones, regulatory news, and sales updates in a clear public channel.
- Investor updates support awareness.
- Press releases track product progress.
- Clinicians see clinical milestones.
- Market watchers get timely signals.
How Catheter Precision Drives Adoption in EP Hospitals
Catheter Precision, Inc. promotes through physician education, conference outreach, and direct hospital selling, because electrophysiology buying is clinical and committee-led. Its message ties VIVO, Amigo, and LockeT to precision, workflow fit, and less invasive use. In 2025, investor updates and press releases also kept product milestones visible.
| Channel | Role | Signal |
|---|---|---|
| Physician education | Drive adoption | Clinical value |
| Hospital outreach | Win committees | Workflow and reimbursement |
| Press releases | Build awareness | Product and regulatory news |
Price
No public list price
Catheter Precision, Inc. does not publish a standard public list price, so buyers usually get a quote from hospitals, distributors, or the sales team. In medical devices, pricing is often contract-based and varies by account, volume, and procedure mix. Public materials focus on clinical value and adoption, not a sticker price.
Hospital contracts
Hospital contracts for Catheter Precision, Inc. are likely negotiated with hospitals and health systems, so the final price depends on contract terms, not list price. Institutional buyers usually push for volume discounts and tighter service scopes, which can lower per-unit pricing. That matters in medtech, where a few large accounts can drive a meaningful share of sales.
Product-specific pricing
Catheter Precision, Inc. should price VIVO, LockeT, and Amigo separately because they sit in different buckets: capital systems, accessories, and procedural tools. In medtech, capital equipment usually carries higher upfront pricing, while disposables and procedure aids are sold at lower unit prices but higher volume. That means each product can use its own model, from one-time system sales to recurring per-use pricing.
Reimbursement sensitivity
Catheter Precision, Inc. pricing has to clear hospital reimbursement math: if a device does not fit DRG or APC payment, adoption slows. Buyers judge whether it cuts procedure time, lowers 1-day readmissions, and improves outcomes enough to justify the bill. In practice, a 1% cost gap can matter less than proof of net savings.
- Reimbursement drives buying.
- Efficiency beats sticker price.
- Outcomes support value-based pricing.
Quote-based sales
Catheter Precision, Inc. likely uses quote-based pricing for electrophysiology systems sold to hospitals and labs, because institutional buyers negotiate on service, training, and bundle size. Final price can shift by customer, volume, and configuration, so list price is less important than the quoted deal terms. In 2025, this model fit a market where hospital purchasing is often contract-led, not shelf-priced.
- Institutional buyers negotiate each deal.
- Volume and configuration change price.
- Service and training can be bundled.
Catheter Precision Pricing: Quoted Deals, Not Public List Prices
Catheter Precision, Inc. uses quote-based pricing, not a public list price, so hospitals negotiate by account, volume, and bundle. Capital products like VIVO usually price differently from accessories and procedural tools, and final deals often include training and service. Reimbursement and proof of procedure savings drive adoption more than sticker price.
| Price factor | What it means |
|---|---|
| List price | Not publicly disclosed |
| Deal method | Quoted per hospital |
| Drivers | Volume, mix, service |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.